Description

Inspire Medical Systems: What The New Center Opening Strategy Reveals About The Next Growth Phase!

Inspire Medical Systems, a company focused on innovating treatments for Obstructive Sleep Apnea (OSA), showcased mixed results and future projections in their recent quarter. The financial and operational highlights for the third quarter of 2025 shed light on the company’s current standing and future direction. Inspire demonstrated a solid revenue performance for the third quarter, achieving $224.5 million, which marks a 10% increase from the same period last year. This growth was reinforced by U.S. revenue climbing 9% to $214.4 million and international revenue growing by 37% to $10.1 million. The company’s gross margin improved to 85.8% compared to 84.1% in the previous year, attributed to the increased sales volume and cost-effective production of the Inspire V system. The company has reaffirmed its annual revenue guidance of $900 million to $910 million, reflecting a 12% to 13% year-over-year growth. However, despite their robust revenue performance, operating income decreased to $9.